Cargando…
PPARγ activation serves as therapeutic strategy against bladder cancer via inhibiting PI3K-Akt signaling pathway
BACKGROUND: Heterogeneity in bladder cancer results in variable clinical outcomes, posing challenges for clinical management of this malignancy. Recent studies suggest both tumor suppressive and oncogenic role of PPARγ in bladder cancer. The fuction of PPARγ signaling pathway in modulating carcinoge...
Autores principales: | Lv, Shidong, Wang, Wei, Wang, Hongyi, Zhu, Yongtong, Lei, Chengyong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6407222/ https://www.ncbi.nlm.nih.gov/pubmed/30845932 http://dx.doi.org/10.1186/s12885-019-5426-6 |
Ejemplares similares
-
2-Methoxyestradiol Induces Vasodilation by Stimulating NO Release via PPARγ/PI3K/Akt Pathway
por: Chen, Weiyu, et al.
Publicado: (2015) -
The role and function of PPARγ in bladder cancer
por: Peng, Tianchen, et al.
Publicado: (2020) -
Assessment of PI3K/mTOR/AKT Pathway Elements to Serve as Biomarkers and Therapeutic Targets in Penile Cancer
por: Thomas, Anita, et al.
Publicado: (2021) -
MiR-27a promotes insulin resistance and mediates glucose metabolism by targeting PPAR-γ-mediated PI3K/AKT signaling
por: Chen, Tianbao, et al.
Publicado: (2019) -
PPAR-γ Ligands Repress TGFβ-Induced Myofibroblast Differentiation by Targeting the PI3K/Akt Pathway: Implications for Therapy of Fibrosis
por: Kulkarni, Ajit A., et al.
Publicado: (2011)